Winton Group LTD Acadia Pharmaceuticals Inc Transaction History
Winton Group LTD
- $1.72 Billion
- Q2 2025
A detailed history of Winton Group LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Winton Group LTD holds 25,200 shares of ACAD stock, worth $572,040. This represents 0.03% of its overall portfolio holdings.
Number of Shares
25,200Holding current value
$572,040% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
350Shares Held
164MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$974 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$346 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$274 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$204 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$140 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.67B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...